Professional societies have stepped up efforts to minimize administered activity, based on updated dosage cards and guidelines. Medical physicists recognize that while these protocols are helpful, there is room for improvement.

Reportlinker.com has released a new report, Magnetic Resonance Imaging Systems: Global Market Outlook 2012-2022, that finds that MRI represents the fastest growing segment of the global medical imaging market.

Iodine-131 is lauded for its specificity in targeting thyroid lesions. Yet, some experts are debating whether the treatment should be used across the board or stratified.

While whole-body oncology imaging advances are still emerging, the best modality remains to be seen.

In 2011, the FDA cleared I-123 ioflupane for dopamine transporter imaging, and an SNM expert provides coding advice for Parkinsonian syndromes.

Advancements in molecular neuroimaging are providing new ways to assess neuroinflammation in the brain.

With the aging population, the proliferation of neurodegenerative diseases, particularly Alzheimers, is becoming a truly global burden.

Carestream received U.S. Food and Drug Administration (FDA) clearance for its DRX-Revolution Mobile X-Ray System, and is now available in the U.S., along with Europe and Canada.